Highlights
- Gujarat Themis Biosyn shares surged over 17% and emerged among NSE top gainers.
- The rally followed the company’s latest quarterly earnings announcement and heavy trading activity.
- Traders are monitoring whether the stock can sustain momentum above key support levels.
Overview
Gujarat Themis Biosyn Limited (NSE: GUJTHEM) witnessed a sharp rally on May 27, 2026, with the stock closing near INR 432.20, up 17.54% for the session. The counter remained in focus after the company released its latest quarterly earnings update earlier this week.
The sharp upside move came alongside strong trading volumes, placing the stock among the top gainers on the NSE during the session. The rally also extended the broader recovery seen in the stock over recent weeks.
Fundamental View
For the quarter ended March 2026, Gujarat Themis Biosyn reported standalone total income of INR 4,515.41 lakh. Profit before tax stood at INR 1,433.65 lakh, while net profit came in at INR 1,089.12 lakh.
The latest earnings announcement reflected continued profitability, which may have supported renewed investor interest in the counter. Market participants are likely to track future earnings consistency and operational performance in upcoming quarters.
Technical View
GUJTHEM closed near INR 432.20 while trading above its 21-day moving average near INR 375.41, reflecting a positive near-term structure. Recent price action indicates strong upward momentum after the stock rebounded from lower levels seen during March and April.
The 14-day RSI moved near 68.13, indicating improving momentum conditions following the sharp rally. Price action suggests traders are closely monitoring whether the stock can sustain above recent breakout levels amid elevated volatility.
Key Technical Levels
- Immediate Support: INR 410.00
- Secondary Support: INR 380.00
- Immediate Resistance: INR 455.00
- Next Resistance Zone: INR 480.00
Risks to Watch
- Sharp rallies may attract near-term profit booking pressure.
- Volatility could remain elevated after the recent price expansion.
- Any weak earnings trend may affect sentiment.
- Small-cap pharmaceutical stocks can witness rapid price swings.
Summary
Gujarat Themis Biosyn shares surged more than 17% after the latest quarterly earnings announcement, supported by strong trading activity and improving momentum. The company reported profitability in the March 2026 quarter, which appeared to strengthen investor sentiment. Traders may continue monitoring whether the stock sustains above support near INR 410.00 while resistance remains around INR 455.00–480.00.
FAQs
Why did Gujarat Themis Biosyn shares rally sharply today?
The stock gained after the latest earnings update, supported by strong momentum and rising trading activity on the NSE.
What are the key support levels for Gujarat Themis Biosyn?
Immediate support is placed near INR 410.00, followed by a broader support zone around INR 380.00.
What resistance levels are traders watching in GUJTHEM stock?
Traders are monitoring resistance near INR 455.00 and the next upside zone around INR 480.00.